Yu John S 4
4 · Kairos Pharma, LTD. · Filed Nov 26, 2025
Insider Transaction Report
Form 4
Yu John S
DirectorCEO and Chairman10% Owner
Transactions
- Award
COMMON STOCK
2025-10-08+190,840→ 230,105 total
Holdings
- 5,316,572(indirect: By Trust)
COMMON STOCK
Footnotes (2)
- [F1]Represents 190,840 restricted stock units ("RSUs") issued to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan. The 190,840 RSUs are scheduled to vest in full on the first anniversary of the grant date.
- [F2]Consists of (1) 34,599 shares of common stock (2) 195,506 RSUs which remain subject to vesting.